Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

12.0%

3 terminated out of 25 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

32%

8 trials in Phase 3/4

Results Transparency

17%

2 of 12 completed with results

Key Signals

2 with results80% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (6)
P 3 (4)
P 4 (4)

Trial Status

Completed12
Not Yet Recruiting5
Unknown3
Terminated3
Active Not Recruiting1
Recruiting1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT06998030Completed

Silent Threat: Impact of Preoperative Albumin Levels on Outcomes in Geriatric Cancer Surgery

NCT07435922Not Yet RecruitingPrimary

Evaluate Recombinant Human Serum Albumin From Oryza Sativa In Patients With Hypoalbuminemia and/or Hypovolemia Requiring Urgent Treatment

NCT07186478Not ApplicableActive Not Recruiting

I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis

NCT07116239Not ApplicableNot Yet Recruiting

Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome

NCT06961825Not ApplicableNot Yet Recruiting

Brief Title: The Role of Nutrition in the Rehabilitation of Patients With Eating Disorders After a Vascular Stroke.

NCT06792448Not Yet Recruiting

Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study

NCT05797649Recruiting

Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)

NCT06681415Phase 4Completed

Efficacy of 20% Human Albumin in Reducing Pleural Effusion After Cardiopulmonary Bypass

NCT06563089Not Yet RecruitingPrimary

Hypoalbuminemia in Critically Sick Children

NCT06355479Phase 3CompletedPrimary

A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia

NCT04071041Phase 3Terminated

Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia.

NCT04046263Phase 4Completed

Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients

NCT02457702Not ApplicableTerminated

Mitochondrial Function in Patients With Severe Liver Disease

NCT05050851UnknownPrimary

Nutritional Parameters and Other Risk Factors Affecting Severity of Pneumonia in Children Under Five Years in Upper Egypt

NCT03167645Phase 4CompletedPrimary

SUbstition of PERioperative Albumin Deficiency Disorders

NCT00597025Not ApplicableCompleted

Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin

NCT01822600Phase 4Completed

The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia

NCT03675906UnknownPrimary

The Relationship Between Hypoalbuminemia and Development of Acute Kidney Failure (AKI) According to KDIGO Criteria

NCT03569410Not ApplicableCompleted

The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients

NCT00529633Phase 3TerminatedPrimary

The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients

Scroll to load more

Research Network

Activity Timeline